Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 70

1.

Influence of dendritic cells on viral pathogenicity.

Freer G, Matteucci D.

PLoS Pathog. 2009 Jul;5(7):e1000384. doi: 10.1371/journal.ppat.1000384. Epub 2009 Jul 31. Review.

2.

Immunotherapy with internally inactivated virus loaded dendritic cells boosts cellular immunity but does not affect feline immunodeficiency virus infection course.

Freer G, Matteucci D, Mazzetti P, Tarabella F, Ricci E, Bozzacco L, Merico A, Pistello M, Ceccherini-Nelli L, Bendinelli M.

Retrovirology. 2008 Apr 17;5:33. doi: 10.1186/1742-4690-5-33.

3.

Evaluation of feline monocyte-derived dendritic cells loaded with internally inactivated virus as a vaccine against feline immunodeficiency virus.

Freer G, Matteucci D, Mazzetti P, Tarabella F, Catalucci V, Ricci E, Merico A, Bozzacco L, Pistello M, Bendinelli M.

Clin Vaccine Immunol. 2008 Mar;15(3):452-9. doi: 10.1128/CVI.00421-07. Epub 2008 Jan 23.

4.

Human immunodeficiency virus integrase inhibitors efficiently suppress feline immunodeficiency virus replication in vitro and provide a rationale to redesign antiretroviral treatment for feline AIDS.

Savarino A, Pistello M, D'Ostilio D, Zabogli E, Taglia F, Mancini F, Ferro S, Matteucci D, De Luca L, Barreca ML, Ciervo A, Chimirri A, Ciccozzi M, Bendinelli M.

Retrovirology. 2007 Oct 30;4:79.

5.

Effects of feline immunodeficiency virus on feline monocyte-derived dendritic cells infected by spinoculation.

Freer G, Matteucci D, Mazzetti P, Tarabella F, Catalucci V, Bendinelli M.

J Gen Virol. 2007 Sep;88(Pt 9):2574-82.

PMID:
17698669
6.

Role of Env in resistance of feline immunodeficiency virus (FIV)-infected cats to superinfection by a second FIV strain as determined by using a chimeric virus.

Giannecchini S, Pistello M, Isola P, Matteucci D, Mazzetti P, Freer G, Bendinelli M.

J Virol. 2007 Oct;81(19):10474-85. Epub 2007 Jul 18.

7.

AIDS vaccination studies with an ex vivo feline immunodeficiency virus model: analysis of the accessory ORF-A protein and DNA as protective immunogens.

Pistello M, Bonci F, Flynn JN, Mazzetti P, Isola P, Zabogli E, Camerini V, Matteucci D, Freer G, Pelosi P, Bendinelli M.

J Virol. 2006 Sep;80(18):8856-68.

8.

Generation of feline dendritic cells derived from peripheral blood monocytes for in vivo use.

Freer G, Matteucci D, Mazzetti P, Bozzacco L, Bendinelli M.

Clin Diagn Lab Immunol. 2005 Oct;12(10):1202-8.

9.

Adoptive immunotherapy of feline immunodeficiency virus with autologous ex vivo-stimulated lymphoid cells modulates virus and T-cell subsets in blood.

Flynn JN, Pistello M, Isola P, Zaccaro L, Del Santo B, Ricci E, Matteucci D, Bendinelli M.

Clin Diagn Lab Immunol. 2005 Jun;12(6):736-45.

10.

Evaluation of feline immunodeficiency virus ORF-A mutants as candidate attenuated vaccine.

Pistello M, Bonci F, Isola P, Mazzetti P, Merico A, Zaccaro L, Matteucci D, Bendinelli M.

Virology. 2005 Feb 20;332(2):676-90.

11.

Vaccination with an inactivated virulent feline immunodeficiency virus engineered to express high levels of Env.

Hosie MJ, Klein D, Binley JM, Dunsford TH, Jarrett O, Neil JC, Knapp E, Giannecchini S, Matteucci D, Bendinelli M, Hoxie JA, Willett BJ.

J Virol. 2005 Feb;79(3):1954-7.

12.

The membrane-proximal tryptophan-rich region in the transmembrane glycoprotein ectodomain of feline immunodeficiency virus is important for cell entry.

Giannecchini S, Bonci F, Pistello M, Matteucci D, Sichi O, Rovero P, Bendinelli M.

Virology. 2004 Mar 1;320(1):156-66.

13.

Evolution of two amino acid positions governing broad neutralization resistance in a strain of feline immunodeficiency virus over 7 years of persistence in cats.

Pistello M, Matteucci D, Giannecchini S, Bonci F, Sichi O, Presciuttini S, Bendinelli M.

Clin Diagn Lab Immunol. 2003 Nov;10(6):1109-16.

14.

AIDS vaccination studies using an ex vivo feline immunodeficiency virus model: protection from an intraclade challenge administered systemically or mucosally by an attenuated vaccine.

Pistello M, Matteucci D, Bonci F, Isola P, Mazzetti P, Zaccaro L, Merico A, Del Mauro D, Flynn N, Bendinelli M.

J Virol. 2003 Oct;77(20):10740-50.

15.
16.

Development of feline immunodeficiency virus ORF-A (tat) mutants: in vitro and in vivo characterization.

Pistello M, Moscardini M, Mazzetti P, Bonci F, Zaccaro L, Isola P, Freer G, Specter S, Matteucci D, Bendinelli M.

Virology. 2002 Jun 20;298(1):84-95.

17.
18.
19.

Densitometric analysis of Western blot assays for feline immunodeficiency virus antibodies.

Calandrella M, Matteucci D, Mazzetti P, Poli A.

Vet Immunol Immunopathol. 2001 May 30;79(3-4):261-71.

PMID:
11389960
20.
22.

Immunogenicity of an anti-clade B feline immunodeficiency fixed-cell virus vaccine in field cats.

Matteucci D, Poli A, Mazzetti P, Sozzi S, Bonci F, Isola P, Zaccaro L, Giannecchini S, Calandrella M, Pistello M, Specter S, Bendinelli M.

J Virol. 2000 Dec;74(23):10911-9.

23.

[Human herpesvirus 6 A enhances HIV-1 replication in vitro by soluble mediators, this effect is diminished by endotoxin].

Ongrádi J, Ceccherini-Nelli L, Matteucci D, Bertók L, Bendinelli M.

Orv Hetil. 1999 Nov 14;140(46):2577-80. Review. Hungarian.

PMID:
10628199
24.
25.

Kinetics of replication of a partially attenuated virus and of the challenge virus during a three-year intersubtype feline immunodeficiency virus superinfection experiment in cats.

Pistello M, Matteucci D, Cammarota G, Mazzetti P, Giannecchini S, Del Mauro D, Macchi S, Zaccaro L, Bendinelli M.

J Virol. 1999 Feb;73(2):1518-27.

26.

AIDS vaccination studies using an ex vivo feline immunodeficiency virus model: detailed analysis of the humoral immune response to a protective vaccine.

Mazzetti P, Giannecchini S, Del Mauro D, Matteucci D, Portincasa P, Merico A, Chezzi C, Bendinelli M.

J Virol. 1999 Jan;73(1):1-10.

27.

A colorimetric reverse transcriptase assay optimized for Moloney murine leukemia virus, and its use for characterization of reverse transcriptases of unknown identity.

Malmsten A, Ekstrand DH, Akerblom L, Gronowitz JS, Källander CF, Bendinelli M, Matteucci D.

J Virol Methods. 1998 Nov;75(1):9-20.

PMID:
9820570
28.

AIDS vaccination studies using an ex vivo feline immunodeficiency virus model: homologous erythrocytes as a delivery system for preferential immunization with putative protective antigens.

Chiarantini L, Matteucci D, Pistello M, Mancini U, Mazzetti P, Massi C, Giannecchini S, Lonetti I, Magnani M, Bendinelli M.

Clin Diagn Lab Immunol. 1998 Mar;5(2):235-41.

29.

Autologous and heterologous neutralization analyses of primary feline immunodeficiency virus isolates.

Del Mauro D, Matteucci D, Giannecchini S, Maggi F, Pistello M, Bendinelli M.

J Virol. 1998 Mar;72(3):2199-207.

30.

Effect of enzymatic deglycosylation on feline immunodeficiency virus sensitivity to antibody-mediated neutralization.

Giannecchini S, Matteucci D, Bendinelli M.

AIDS Res Hum Retroviruses. 1998 Feb 10;14(3):199-204.

PMID:
9491909
31.

Studies of AIDS vaccination using an ex vivo feline immunodeficiency virus model: protection conferred by a fixed-cell vaccine against cell-free and cell-associated challenge differs in duration and is not easily boosted.

Matteucci D, Pistello M, Mazzetti P, Giannecchini S, Del Mauro D, Lonetti I, Zaccaro L, Pollera C, Specter S, Bendinelli M.

J Virol. 1997 Nov;71(11):8368-76.

32.

Analysis of the genetic diversity and phylogenetic relationship of Italian isolates of feline immunodeficiency virus indicates a high prevalence and heterogeneity of subtype B.

Pistello M, Cammarota G, Nicoletti E, Matteucci D, Curcio M, Del Mauro D, Bendinelli M.

J Gen Virol. 1997 Sep;78 ( Pt 9):2247-57.

PMID:
9292012
33.

Most potential linear B cell epitopes of Env glycoproteins of feline immunodeficiency virus are immunogenically silent in infected cats.

Massi C, Lombardi S, Indino E, Matteucci D, La Rosa C, Esposito F, Garzelli C, Bendinelli M.

AIDS Res Hum Retroviruses. 1997 Sep 1;13(13):1121-9.

PMID:
9282817
34.

Quantitation of feline immunodeficiency proviruses in doubly infected cats using competitive PCR and a fluorescence-based RFLP.

Cammarota G, Da Prato L, Nicoletti E, Matteucci D, Bendinelli M, Pistello M.

J Virol Methods. 1996 Oct;62(1):21-31.

PMID:
8910645
35.

Incubation time for feline immunodeficiency virus cultures.

Giannecchini S, Matteucci D, Mazzetti P, Bendinelli M.

J Clin Microbiol. 1996 Aug;34(8):2036-8.

36.

Reduced sensitivity to strain-specific neutralization of laboratory-adapted feline immunodeficiency virus after one passage in vivo: association with amino acid substitutions in the V4 region of the surface glycoprotein.

Cammarota G, Matteucci D, Pistello M, Nicoletti E, Giannecchini S, Bendinelli M.

AIDS Res Hum Retroviruses. 1996 Jan 20;12(2):173-175. No abstract available.

PMID:
8834468
37.

Vaccination protects against in vivo-grown feline immunodeficiency virus even in the absence of detectable neutralizing antibodies.

Matteucci D, Pistello M, Mazzetti P, Giannecchini S, Del Mauro D, Zaccaro L, Bandecchi P, Tozzini F, Bendinelli M.

J Virol. 1996 Jan;70(1):617-22.

38.

Examination of variables affecting syncytium formation by, and serum neutralization of, feline immunodeficiency virus on CrFK cells.

Bandecchi P, Pistello M, Matteucci D, Lombardi S, Bendinelli M, Tozzini F.

New Microbiol. 1995 Jul;18(3):241-52.

PMID:
7553358
39.

The feline lymphoid cell line MBM and its use for feline immunodeficiency virus isolation and quantitation.

Matteucci D, Mazzetti P, Baldinotti F, Zaccaro L, Bendinelli M.

Vet Immunol Immunopathol. 1995 May;46(1-2):71-82.

PMID:
7618261
40.

FIV infection of macrophages: in vitro and in vivo inhibition by dideoxycytidine 5'-triphosphate.

Magnani M, Rossi L, Fraternale A, Silvotti L, Quintavalla F, Piedimonte G, Matteucci D, Baldinotti F, Bendinelli M.

Vet Immunol Immunopathol. 1995 May;46(1-2):151-8.

PMID:
7618255
41.

Renal involvement in feline immunodeficiency virus infection: p24 antigen detection, virus isolation and PCR analysis.

Poli A, Abramo F, Matteucci D, Baldinotti F, Pistello M, Lombardi S, Barsotti P, Bendinelli M.

Vet Immunol Immunopathol. 1995 May;46(1-2):13-20.

PMID:
7618253
42.

Feline immunodeficiency virus: an interesting model for AIDS studies and an important cat pathogen.

Bendinelli M, Pistello M, Lombardi S, Poli A, Garzelli C, Matteucci D, Ceccherini-Nelli L, Malvaldi G, Tozzini F.

Clin Microbiol Rev. 1995 Jan;8(1):87-112. Review.

43.

A neutralizing antibody-inducing peptide of the V3 domain of feline immunodeficiency virus envelope glycoprotein does not induce protective immunity.

Lombardi S, Garzelli C, Pistello M, Massi C, Matteucci D, Baldinotti F, Cammarota G, da Prato L, Bandecchi P, Tozzini F, et al.

J Virol. 1994 Dec;68(12):8374-9.

44.

Feline immunodeficiency virus infection of macrophages: in vitro and in vivo inhibition by dideoxycytidine-5'-triphosphate-loaded erythrocytes.

Magnani M, Rossi L, Fraternale A, Silvotti L, Quintavalla F, Piedimonte G, Matteucci D, Baldinotti F, Bendinelli M.

AIDS Res Hum Retroviruses. 1994 Sep;10(9):1179-86.

PMID:
7826702
45.

Serum neutralization of feline immunodeficiency virus is markedly dependent on passage history of the virus and host system.

Baldinotti F, Matteucci D, Mazzetti P, Giannelli C, Bandecchi P, Tozzini F, Bendinelli M.

J Virol. 1994 Jul;68(7):4572-9.

46.

Enhancement of plasma levels of tumor necrosis factor alpha but not interleukin-6 following endotoxin injection of Friend leukemia virus infected mice.

Soldaini E, Baldinotti F, Matteucci D, Specter S, Bendinelli M.

J Biol Regul Homeost Agents. 1994 Jan-Mar;8(1):25-31.

PMID:
7976491
47.

Neutralizing antibodies in cats infected with feline immunodeficiency virus.

Tozzini F, Matteucci D, Bandecchi P, Baldinotti F, Siebelink K, Osterhaus A, Bendinelli M.

J Clin Microbiol. 1993 Jun;31(6):1626-9.

48.

Detection of feline immunodeficiency virus in saliva and plasma by cultivation and polymerase chain reaction.

Matteucci D, Baldinotti F, Mazzetti P, Pistello M, Bandecchi P, Ghilarducci R, Poli A, Tozzini F, Bendinelli M.

J Clin Microbiol. 1993 Mar;31(3):494-501.

49.

Small animal model of AIDS and the feline immunodeficiency virus.

Bendinelli M, Pistello M, Matteucci D, Lombardi S, Baldinotti F, Bandecchi P, Ghilarducci R, Ceccherini-Nelli L, Garzelli C, Poli A, et al.

Adv Exp Med Biol. 1993;335:189-202. Review. No abstract available.

PMID:
8237595
50.

Simple in vitro methods for titrating feline immunodeficiency virus (FIV) and FIV neutralizing antibodies.

Tozzini F, Matteucci D, Bandecchi P, Baldinotti F, Poli A, Pistello M, Siebelink KH, Ceccherini-Nelli L, Bendinelli M.

J Virol Methods. 1992 Jun;37(3):241-52.

PMID:
1321834

Supplemental Content

Loading ...
Support Center